Creo Medical Group PLC (LON:CREO) traded up 3.1% on Thursday . The stock traded as high as GBX 165.50 ($2.16) and last traded at GBX 164 ($2.14), 113,397 shares changed hands during mid-day trading. An increase of 606% from the average session volume of 16,051 shares. The stock had previously closed at GBX 159 ($2.08).
The company has a debt-to-equity ratio of 2.00, a current ratio of 9.50 and a quick ratio of 9.36. The firm has a market cap of $199.94 million and a price-to-earnings ratio of -13.60. The firm has a fifty day simple moving average of GBX 141.49 and a two-hundred day simple moving average of GBX 173.06.
In other Creo Medical Group news, insider Charles Spicer purchased 14,220 shares of the stock in a transaction on Tuesday, August 6th. The stock was acquired at an average price of GBX 141 ($1.84) per share, with a total value of £20,050.20 ($26,199.14).
Creo Medical Group Company Profile (LON:CREO)
Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection.
Recommended Story: What are the reasons investors use put options?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.